Granularity in disease classification impacts survival prediction in advanced systemic mastocytosis: A single institution study of 329 informative cases
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Granularity in disease classification impacts survival prediction in advanced systemic mastocytosis: A single institution study of 329 informative cases
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HEMATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-09-29
DOI
10.1002/ajh.27113
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The international consensus classification of eosinophilic disorders and systemic mastocytosis
- (2023) Sa A. Wang et al. AMERICAN JOURNAL OF HEMATOLOGY
- Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management
- (2023) Animesh Pardanani AMERICAN JOURNAL OF HEMATOLOGY
- Reappraisal of mast cell leukemia based on a single institution review of 16 cases: Mast cell morphology determines clinical outcome
- (2023) Animesh Pardanani et al. AMERICAN JOURNAL OF HEMATOLOGY
- Mast cell cytomorphology and treatment outcome in mast cell leukemia
- (2023) Ayalew Tefferi et al. AMERICAN JOURNAL OF HEMATOLOGY
- Midostaurin therapy for advanced systemic mastocytosis: Mayo Clinic experience in 33 consecutive cases
- (2022) Amritpal Singh et al. AMERICAN JOURNAL OF HEMATOLOGY
- Midostaurin therapy for indolent and smoldering systemic mastocytosis: Retrospective review of Mayo Clinic experience
- (2022) Faiqa Farrukh et al. AMERICAN JOURNAL OF HEMATOLOGY
- Mast cell sarcoma: 2 Mayo Clinic cases
- (2022) Amritpal Singh et al. AMERICAN JOURNAL OF HEMATOLOGY
- International Consensus Classification of Myeloid Neoplasms and Acute Leukemia: Integrating Morphological, Clinical, and Genomic Data
- (2022) Daniel A. Arber et al. BLOOD
- Efficacy of avapritinib versus best available therapy in the treatment of advanced systemic mastocytosis
- (2022) Andreas Reiter et al. LEUKEMIA
- The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
- (2022) Joseph D. Khoury et al. LEUKEMIA
- Diagnostic and therapeutic challenges in mast cell sarcoma
- (2022) Francesco Mannelli et al. AMERICAN JOURNAL OF HEMATOLOGY
- Cladribine therapy for advanced and indolent systemic mastocytosis: Mayo Clinic experience in 42 consecutive cases
- (2021) Ayalew Tefferi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial
- (2021) Jason Gotlib et al. NATURE MEDICINE
- Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial
- (2021) Daniel J. DeAngelo et al. NATURE MEDICINE
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
- (2016) D. A. Arber et al. BLOOD
- Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis
- (2016) Jason Gotlib et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mast cell leukemia
- (2012) S. Georgin-Lavialle et al. BLOOD
- Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine
- (2009) Ken H. Lim et al. AMERICAN JOURNAL OF HEMATOLOGY
- Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors
- (2009) K.-H. Lim et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now